ROCHE HOLDING AG Pricing & Demo

Are you from this Company?
ROCHE HOLDING AG
53 Likes
85 Buyers Negotiating
Strengths
  • +5
    Therapy Selection
  • +13
    Clinical Use
  • +14
    Assay kits
  • +7
    Blood
  • +9
    Circulating Tumor Cells (CTCs)
  • +5
    Instruments
  • +14
    Breadth and Depth of Product Offerings
  • +5
    Product Features and Functionality
  • +6
    Treatment Monitoring
  • +7
    Product Differentiation and Impact on Customer Value
  • +6
    Focus on Product Innovation
  • +8
    New Liquid Biopsy Products launched in the last four years
  • +10
    Circulating Tumor DNA (ctDNA)
  • +11
    Cell-Free DNA (cfDNA)
  • +12
    Research Use
  • +8
    Urine
  • +9
    Others (Saliva, other body fluids)
  • +12
    Extracellular Vesicles (EVs)
  • +14
    Early Cancer Screening
  • +13
    Other Circulating Biomarkers
Cautions
  • -7
    Recurrence Monitoring
  • -6
    Services

ROCHE HOLDING AG Reviews

user-icon

Buyer, UK Mid Market Company

5
Feb 09, 2023
Technical Features: I recently purchased a ROCHE HOLDING AGs Liquid Biopsy which offers a novel method of diagnosing various cancer types with high accuracy. The product is quite advanced, as it makes use of specific microfluidic pleurosampling technology that is able to enable high definition oncology testing against a wide range of diseases. Its also designed to enable easy extraction and amplification of the captured specimen for accurate diagnosis and analysis. The product also offers great degree of sensitivity and accuracy that is trusted by healthcare institutions. Cost: The cost of the product is relatively reasonable too. ROCHE HOLDING AGs Liquid Biopsy offers a price tag that is quite reasonable and affordable, which makes it a great alternative to traditional methods that have a much higher cost. ROCHE also offers a payment plan for this product, which really helps to reduce the overall cost. All in all, Id rate the cost of the product a 4 out of 5 because of the overall reasonable pricing. Support: Im also quite impressed with the level of support I received when I purchased the product. ROCHE offers a great customer service level where their staff is always willing to answer any questions and offer helpful advice. Additionally, they also offer a 24/7 hotline that one can use in case of any technical difficulties. In terms of customer support, Id rate ROCHE 5 out of
Read less Read more
Useful (0) Not useful (0)
user-icon

Buyer, UK SME Company

5
Feb 02, 2023
ROI: ROCHE HOLDING AGs Liquid Biopsy also offers great return on investment. The product can be used multiple times, and it can prove to be an invaluable tool for diagnostic purposes. For instance, it can decrease the time to diagnose and treat cancer, as well as reduce costs associated with diagnostic testing. The quick diagnostics and the savings made makes for an excellent return on investment for ROCHEs Liquid Biopsy. Id rate the ROI a 5 out of 5. Financial Stability & Business Maturity: ROCHE has been around for quite a long time, and has established itself as one of the leaders in the diagnostic medicine industry. This is evidenced by the stability and maturity of the business, and its ability to consistently offer excellent services and products. By choosing ROCHE, I know that Im getting a product from a reliable source. Id rate the financial stability and business maturity a 5 out of
Read less Read more
Useful (0) Not useful (0)
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup